🇺🇸 FDA
Patent

US 8900880

Viral citrullinated peptides and uses thereof

granted A61KA61K38/00

Quick answer

US patent 8900880 (Viral citrullinated peptides and uses thereof) held by Toscana Biomarkers S.R.L. expires Mon Nov 27 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Toscana Biomarkers S.R.L.
Grant date
Tue Dec 02 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 27 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
12
CPC classes
A61K, A61K38/00